Uterine Arteriovenous Malformation Acquired after Cesarean Section: A Case Report  

作　　者：Ana Lúcia Isotton Leandro Armani Scaffaro Ellen Machado Arlindo Anne Bergmann Nicolas Karpouzas Vicentini Janete Vettorazzi Ana Lúcia Isotton;Leandro Armani Scaffaro;Ellen Machado Arlindo;Anne Bergmann;Nicolas Karpouzas Vicentini;Janete Vettorazzi(Service of Obstetrics and Gynecology and Interventional Radiology Department, Hospital Moinhos de Vento, Porto Alegre, Por-to Alegre/RS, Brazil;Medicina Fetal Porto Alegre, Porto Alegre/RS, Brazil;Post Graduation Program in Health Sciences: Gynecology and Obstetrics, Faculdade de Medicina da Universidade Federal do Rio Grande do Sul (UFRGS), RS, Brazil)

机构地区：[1]Service of Obstetrics and Gynecology and Interventional Radiology Department, Hospital Moinhos de Vento, Porto Alegre, Por-to Alegre/RS, Brazil [2]Medicina Fetal Porto Alegre, Porto Alegre/RS, Brazil [3]Post Graduation Program in Health Sciences: Gynecology and Obstetrics, Faculdade de Medicina da Universidade Federal do Rio Grande do Sul (UFRGS), RS, Brazil

出　　处：《Open Journal of Obstetrics and Gynecology》2021年第11期1512-1516,共5页妇产科期刊（英文）

摘　　要：Background: Uterine arteriovenous malformation (AVM) is a rare, potentially life-threatening cause of abnormal uterine bleeding that can be acquired following a cesarean section. The diagnosis is difficult, often misdiagnosed with retained products of conception and placenta accreta. Transarterial embolization (TAE) is a</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">n</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> efficacious and effective method of treating AVM, particularly in patients of reproductive age.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Case Report: A 41-year-old, nulliparous</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> woman</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">, started with a history of abnormal uterine bleeding 30 days after a cesarean section. She didn’t have anaemia and beta-human chorionic gonadotropin (beta-hCG) was negative. The transvaginal color Doppler ultrasound showed multiple vascular channels within myometrium showing colored mosaic patterns suggesting AVM, confirmed by Magnetic Resonance Imaging. The patient was referred to perform a Computed Tomography Angiography and right uterine artery embolization without any vascular complications.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Conclusion: AVM is a rare consequence of cesarean section but has to be considered in cases of persistent uterine bleeding in the puerperium. Embolization is a safe and effective choice treatment of AVM and aBackground: Uterine arteriovenous malformation (AVM) is a rare, potentially life-threatening cause of abnormal uterine bleeding that can be acquired following a cesarean section. The diagnosis is difficult, often misdiagnosed with retained products of conception and placenta accreta. Transarterial embolization (TAE) is a</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">n</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> efficacious and effective method of treating AVM, particularly in patients of reproductive age.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Case Report: A 41-year-old, nulliparous</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> woman</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">, started with a history of abnormal uterine bleeding 30 days after a cesarean section. She didn’t have anaemia and beta-human chorionic gonadotropin (beta-hCG) was negative. The transvaginal color Doppler ultrasound showed multiple vascular channels within myometrium showing colored mosaic patterns suggesting AVM, confirmed by Magnetic Resonance Imaging. The patient was referred to perform a Computed Tomography Angiography and right uterine artery embolization without any vascular complications.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Conclusion: AVM is a rare consequence of cesarean section but has to be considered in cases of persistent uterine bleeding in the puerperium. Embolization is a safe and effective choice treatment of AVM and a

关 键 词：Arteriovenous Malformation Embolization Therapeutic Vaginal Bleeding Cesarean Section 

分 类 号：R73[医药卫生—肿瘤]